[{"address1": "9350 Kirby Drive", "address2": "Suite 300", "city": "Houston", "state": "TX", "zip": "77054", "country": "United States", "phone": "713 400 6400", "website": "https://markertherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Juan F. Vera M.D.", "age": 43, "title": "Co-Founder, CEO, President, Treasurer, Secretary & Director", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 399251, "exercisedValue": 0, "unexercisedValue": 39127}, {"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Administration", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Maria-Bernadette  Madel", "age": 33, "title": "Director of Corporate Operations & External Communications", "yearBorn": 1991, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Monic  Stuart M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Allison", "title": "Head of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Newman Ph.D.", "age": 65, "title": "Head of Regulatory Affairs", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr., Ph.D.", "title": "Senior Director of Molecular Biology & Virology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.27, "open": 1.28, "dayLow": 1.25, "dayHigh": 1.33, "regularMarketPreviousClose": 1.27, "regularMarketOpen": 1.28, "regularMarketDayLow": 1.25, "regularMarketDayHigh": 1.33, "payoutRatio": 0.0, "beta": 1.519, "forwardPE": -0.8904109, "volume": 74659, "regularMarketVolume": 74659, "averageVolume": 134762, "averageVolume10days": 449390, "averageDailyVolume10Day": 449390, "bid": 1.25, "ask": 1.36, "bidSize": 1, "askSize": 1, "marketCap": 13921699, "fiftyTwoWeekLow": 1.13, "fiftyTwoWeekHigh": 5.99, "priceToSalesTrailing12Months": 2.5800757, "fiftyDayAverage": 1.9086, "twoHundredDayAverage": 3.33215, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2333168, "profitMargins": -1.7970799, "floatShares": 5437082, "sharesOutstanding": 10709000, "sharesShort": 137942, "sharesShortPriorMonth": 232134, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0128999995, "heldPercentInsiders": 0.098529994, "heldPercentInstitutions": 0.41807, "shortRatio": 1.8, "shortPercentOfFloat": 0.0179, "impliedSharesOutstanding": 10793300, "bookValue": 0.835, "priceToBook": 1.5568862, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -9633818, "trailingEps": -1.07, "forwardEps": -1.46, "lastSplitFactor": "1:10", "lastSplitDate": 1674777600, "enterpriseToRevenue": 0.432, "52WeekChange": -0.7177778, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 1.3, "targetHighPrice": 19.0, "targetLowPrice": 4.0, "targetMeanPrice": 10.33333, "targetMedianPrice": 8.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 8999664, "totalCashPerShare": 1.009, "totalDebt": 0, "quickRatio": 2.816, "currentRatio": 3.153, "totalRevenue": 5395849, "revenuePerShare": 0.606, "returnOnAssets": -0.41923, "returnOnEquity": -0.79761004, "grossProfits": -5603129, "freeCashflow": -5249834, "operatingCashflow": -8574773, "revenueGrowth": 6.477, "grossMargins": -1.0384101, "ebitdaMargins": 0.0, "operatingMargins": -1.24603, "financialCurrency": "USD", "symbol": "MRKR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "regularMarketChangePercent": 2.3622024, "regularMarketPrice": 1.3, "corporateActions": [], "regularMarketTime": 1742412293, "shortName": "Marker Therapeutics, Inc.", "longName": "Marker Therapeutics, Inc.", "exchange": "NCM", "messageBoardId": "finmb_1725474", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "regularMarketChange": 0.029999971, "regularMarketDayRange": "1.25 - 1.33", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 134762, "fiftyTwoWeekLowChange": 0.16999996, "fiftyTwoWeekLowChangePercent": 0.15044244, "fiftyTwoWeekRange": "1.13 - 5.99", "fiftyTwoWeekHighChange": -4.6899996, "fiftyTwoWeekHighChangePercent": -0.78297156, "fiftyTwoWeekChangePercent": -71.77778, "dividendDate": 1473984000, "earningsTimestampStart": 1742813940, "earningsTimestampEnd": 1743163200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.07, "epsForward": -1.46, "epsCurrentYear": -0.97, "priceEpsCurrentYear": -1.3402061, "fiftyDayAverageChange": -0.6086, "fiftyDayAverageChangePercent": -0.31887248, "twoHundredDayAverageChange": -2.03215, "twoHundredDayAverageChangePercent": -0.6098615, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1026826200000, "displayName": "Marker Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]